Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Featured Jobs

Controller, VP of Administration
Soligenix, Inc. - Princeton, NJ
Opportunity Development Manager – Southwest Territory
The Jackson Laboratory - Southern California, Arizona, Nevada & New Mexico
Vice President, Research
LLS - White Plains, NY
Innovations Adviser
Xpedite Innovations Management - London, UK
Intellectual Property Manager - Medical Devices
Xpedite Innovations Management - London, UK

More Jobs >>

Events

13th Annual C21 BioVentures
May 24-26, 2011 — Napa, CA, USA
Seminars, Practical Considerations for Early Phase Efficiencies
April 28 through May 18, 2011 — Various U.S. Locations
Best Practices for the Prevention of Cargo and Warehouse Theft of FDA-Regulated Medical Products and Infant Formula
May 13, 2011 — Rockville, MD
DIA 2011: Convergence of Science, Medicine, and Health
June 19-23, 2011 — Chicago, Illinois

More Events >>

Related Tags >> Vaccine HIV vaccine AIDS vaccine Merck

HIV/AIDS News

Most Popular HIV/AIDS Story

Two new antibodies may lead to HIV/AIDS vaccine

July 14, 2010 — 3:39pm ET | By Erica Teichert

Federal researchers have discovered two antibodies that may bring about the renaissance of HIV and AIDS treatment. The antibodies, VRC01 and VRC02, can kill up to 90 percent of HIV strains, compared Read more...

HIV/AIDS Press Releases

Phase III Clinical Trial of Gilead's Investigational Elvitegravir Meets 48-Week Primary Objective
Asian efforts in AIDS vaccine development step up
AVAC Calls for AIDS Vaccine Field to Implement New Scientific Strategic Plan Released by Global HIV Vaccine Enterprise
Has HIV Become More Virulent?
Avexa Limited Reports Positive 96 Week Data for HIV Drug Apricitabine (ATC)

Latest Headlines

Scientists: HIV vaccine impacts the genetic makeup of the virus
March 2, 2011
Scientist: "Sleepy" immune system could combat HIV
February 16, 2011
Aaron Diamond team working on HIV vax
November 7, 2010
Duke researchers to test mosaic HIV vax candidate
October 20, 2010
HIV vaccine researchers ponder new strategies, drop in funding
September 29, 2010
AIDS vax group reveals global research strategy
September 8, 2010
New poll taps strong public fear about HIV vaccines
August 5, 2010
New Hutch president looks for real cures among research
August 4, 2010
Funds once earmarked for HIV lab go to research
July 20, 2010
Two new antibodies may lead to HIV/AIDS vaccine
July 14, 2010
Scientists: Smallpox vaccine slowed spread of HIV
May 19, 2010
Decision to scrap HIV vax facility stirs controversy
February 24, 2010
Thai HIV vax trial controversy continues to brew
October 15, 2009
AIDS vax a surprising success in big trial
September 23, 2009
Bioengineered plant makes antibodies against HIV
May 20, 2009
Businessman donates $100M to HIV vaccine institute
February 4, 2009
World AIDS day marked by new vaccine progress
December 4, 2008
T-cell HIV vax still promising
November 12, 2008
HIV vax debacle linked to T-cell activation
November 6, 2008
Nobel winners frustrated, hopeful about AIDS vax
October 9, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK